Stay updated with breaking news from Sera Prognostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative...
GeneLink (OTCMKTS:GNLKQ – Get Rating) and Sera Prognostics (NASDAQ:SERA – Get Rating) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, valuation, risk, institutional ownership, dividends, profitability and analyst recommendations. Risk and Volatility GeneLink has a beta of 0.06, suggesting that […]
Sera Prognostics, Inc. (NASDAQ:SERA – Get Rating) saw a large decline in short interest in March. As of March 31st, there was short interest totalling 242,600 shares, a decline of 23.3% from the March 15th total of 316,100 shares. Based on an average trading volume of 1,310,000 shares, the days-to-cover ratio is currently 0.2 days. […]
Sera Prognostics, Inc. (NASDAQ:SERA – Get Rating) was the target of a large decrease in short interest during the month of March. As of March 15th, there was short interest totalling 316,100 shares, a decrease of 19.9% from the February 28th total of 394,700 shares. Currently, 2.1% of the shares of the company are sold […]
Sera Prognostics, Inc. (NASDAQ:SERA – Get Rating) was the target of a large decrease in short interest in the month of March. As of March 15th, there was short interest totalling 316,100 shares, a decrease of 19.9% from the February 28th total of 394,700 shares. Currently, 2.1% of the company’s shares are short sold. Based […]